Gabriel Bastien
900 St Denis Street, H2X 0A9
Montreal, QC, Canada
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Sex-based effectiveness in buprenorphine/naloxone and methadone treatment for opioid use disorder: Findings from the OPTIMA trial.
Journal: Drug and alcohol dependence
Published: December 01, 2025
Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Prescription-Type Opioid Use Disorder: Concordance entre le dépistage de drogues dans l'urine et l'usage autodéclaré dans le contexte d'un essai pragmatique contrôlé à répartition aléatoire chez des personnes présentant un trouble lié à l'usage d'opioïdes vendus sur ordonnance.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: August 28, 2025
Is Naltrexone Effective and Safe for Treating Amphetamine-Type Stimulant Use Disorder? A Systematic Review and Meta-analysis.
Journal: Journal of addiction medicine
Published: November 26, 2024
Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study.
Journal: Harm reduction journal
Published: September 20, 2024
The effect of craving on retention and treatment switching under buprenorphine-naloxone and methadone models of care for non-heroin opioid use disorder: Exploratory analyses from a pragmatic, randomized controlled trial.
Journal: Journal of substance use and addiction treatment
Published: September 04, 2024
Efficacy and Safety of Modafinil for Treatment of Amphetamine-Type Stimulant Use Disorder: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials: Efficacité et innocuité du modafinil pour le traitement des troubles liés à l'usage de stimulants de type amphétamine : revue systématique et méta-analyse d'essais randomisés contrôlés par placebo.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: July 21, 2024
Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial.
Journal: Journal of dual diagnosis
Published: April 05, 2024
The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: September 12, 2023
Mediating effect of craving on the impact of buprenorphine/naloxone and methadone treatment on opioid use: Results from a randomized controlled trial.
Journal: Addictive behaviors
Published: June 03, 2023
Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: December 15, 2022
Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study.
Journal: Journal of substance use and addiction treatment
Published: August 24, 2022
Variations of cannabis-related adverse mental health and addiction outcomes across adolescence and adulthood: A scoping review.
Journal: Frontiers in psychiatry
Published: June 20, 2022
Last Updated: 09/26/2026